| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |